Citation Impact
Citing Papers
The gut microbiota and host health: a new clinical frontier
2015 Standout
Augmented increase in tight junction permeability by luminal stimuli in the non-inflamed ileum of Crohn's disease
2002
Personal view: food for thought – western lifestyle and susceptibility to Crohn's disease. The FODMAP hypothesis
2005
Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's disease
2005
Infliximab Plus Azathioprine for Steroid-Dependent Crohn’s Disease Patients: A Randomized Placebo-Controlled Trial
2006
European evidence based consensus on the diagnosis and management of Crohn’s disease: current management
2006
The optimal dose of 5-aminosalicylic acid in active ulcerative colitis: A dose-finding study with newly developed mesalamine
2003
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
2013 Standout
Lactobacillus species prevents colitis in interleukin 10 gene–deficient mice
1999
Interactions between the microbiota, immune and nervous systems in health and disease
2017 Standout
Is Caregiving Hazardous to One's Physical Health? A Meta-Analysis.
2003 Standout
Changes of Intestinal Functions in Liver Cirrhosis
2016 Standout
5-Aminosalicylates Prevent Relapse of Crohn's Disease After Surgically Induced Remission: Systematic Review and Meta-Analysis
2010
Intestinal homeostasis and its breakdown in inflammatory bowel disease
2011 StandoutNature
Ulcerative Colitis
2011 Standout
Microbial factors in inflammatory bowel disease
2002
Unravelling the pathogenesis of inflammatory bowel disease
2007 StandoutNature
Early Azathioprine Therapy Is No More Effective Than Placebo for Newly Diagnosed Crohn's Disease
2013
Natural history of Crohn's disease in a population-based cohort from Cardiff (1986–2003): a study of changes in medical treatment and surgical resection rates
2010
A Randomized, Double-Blind, Controlled Withdrawal Trial in Crohn’s Disease Patients in Long-term Remission on Azathioprine
2005
Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease
2003 Standout
Olsalazine is not superior to placebo in maintaining remission of inactive Crohn's colitis and ileocolitis: a double blind, parallel, randomised, multicentre study
2001
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Intestinal Permeation and Gastrointestinal Disease
2002
Increased intestinal permeability precedes the onset of Crohn's disease in a subject with familial risk
2000
Crohn's disease
2012 Standout
Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria
2009 Standout
Unconventional Medicine in the United States -- Prevalence, Costs, and Patterns of Use
1993 Standout
The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based study
2001 Standout
Inflammatory bowel disease: cause and immunobiology
2007 Standout
Inflammatory Bowel Disease
2009 Standout
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
The influence of normal microbial flora on the development of chronic mucosal inflammation
1997
Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European cooperative Crohn's disease study VI
2000
Inflammation and Colon Cancer
2010 Standout
Microbial Influences in Inflammatory Bowel Diseases
2008
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
2001 StandoutNature
Impact of the increasing use of immunosuppressants in Crohn’s disease on the need for intestinal surgery
2005
Ulcerative colitis
2012 Standout
Ornidazole for prophylaxis of postoperative Crohn’s disease recurrence: A randomized, double-blind, placebo-controlled trial
2005
A Diet Low in FODMAPs Reduces Symptoms of Irritable Bowel Syndrome
2013 Standout
Tumor necrosis factor inhibitor ameliorates murine intestinal graft-versus-host disease
1999 StandoutNobel
Crohn's disease
2016 Standout
The Role of Microbes in Crohn's Disease
2006
Mechanisms of action of probiotics: Recent advances
2008
Inflammatory Bowel Disease
2002 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Intestinal mucosal barrier function in health and disease
2009 Standout
Meta‐analysis: the efficacy of azathioprine and mercaptopurine in ulcerative colitis
2009
CD4 and CD8 Counts Are Associated With Interactions of Gender and Psychosocial Stress
1998
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
2002 Standout
Funnel plots for detecting bias in meta-analysis
2001 Standout
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
2004 Standout
Infliximab Prevents Crohn's Disease Recurrence After Ileal Resection
2008
Pharmacokinetic Considerations in the Treatment of Inflammatory Bowel Disease
2001
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
2010
Factors associated with acceptance and full publication of GI endoscopic research originally published in abstract form
2001
Postoperative maintenance of Crohn’s disease remission with 6-mercaptopurine, mesalamine, or placebo: A 2-year trial
2004
Oral contraceptive use and smoking are risk factors for relapse in Crohn's disease
1998
Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences
2004 Standout
Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study
2009
Epidemiology and Natural History of Inflammatory Bowel Diseases
2011 Standout
Inflammatory bowel disease: Etiology and pathogenesis
1998 Standout
Psychological Stress and the Human Immune System: A Meta-Analytic Study of 30 Years of Inquiry.
2004 Standout
AGA technical review on irritable bowel syndrome
2002 Standout
Early Life Stress Triggers Persistent Colonic Barrier Dysfunction and Exacerbates Colitis in Adult IL-10−/− Mice
2013
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010 Standout
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
Management of Crohn's Disease in Adults
2009 Standout
Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens
2008 Standout
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
2007 Standout
A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease
2002
Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn’s disease
2004
Guidelines for the management of inflammatory bowel disease in adults
2004
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
The gut microbiota shapes intestinal immune responses during health and disease
2009 Standout
An Evidence-Based Systematic Review on Medical Therapies for Inflammatory Bowel Disease
2011
Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohnʼs disease
2009
Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis
2006
Gut Microbiota in Health and Disease
2010 Standout
Maintenance Therapy in Crohn's Disease
2000
Immunity, Inflammation, and Allergy in the Gut
2005 Science
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
2007 Standout
Commensal Host-Bacterial Relationships in the Gut
2001 StandoutScience
Excess risk of urinary tract cancers in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study
2015
Use of alternative medicine by patients attending a gastroenterology clinic.
1990
Full publication of results initially presented in abstracts
2007 Standout
Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's disease
2016
Alternatives to sulfasalazine: A meta-analysis of 5-ASA in the treatment of ulcerative colitis
1997
Inflammatory Bowel Disease
2010 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
A Review of Activity Indices and Efficacy End Points for Clinical Trials of Medical Therapy in Adults With Ulcerative Colitis
2006 Standout
Budesonide for induction of remission in Crohn's disease
2015
Inflammatory bowel disease is associated with changes of enterocytic junctions
2001
European evidence-based Consensus on the management of ulcerative colitis: Current management
2008
Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis
2016
Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease
2015
Regulation of Mammalian Autophagy in Physiology and Pathophysiology
2010 Standout
Works of LR Sutherland being referenced
Azathioprine for maintenance of remission in Crohn's disease
1998
Trends in Inflammatory Bowel Disease Therapy
1993
Intestinal permeability changes in response to acetylsalicylic acid in relatives of patients with Crohn's disease
1996
A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group
1997
The case against routine post-operative therapy for prevention of recurrence in Crohn's disease.
1998
Alternative medicine: what are our patients telling us?
1988
Is there bias in the selection of abstracts for presentation at the DDW?
1998
Acceptance by the aga is the single best indicator of subsequent full publication of research
1998
Nutritional status and food intake in human immunodeficiency virus infection. GI/HIV Study Group.
1992
A Double-Blind, Placebo Controlled, Multicentre Study of the Efficacy And Safety of 5-Aminosalicylic Acid Tablets in the Treatment of Ulcerative Colitis
1990